Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group.
Year: 1998
Type: article
Source: Journal of Clinical Oncology
Authors: G D Demetri, M Kris, J Wade, L Degos, D Cella
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1884165293
